Suchergebnisse - "Bates, Timothy A"

PubPharm (15)

1

Diverging Maternal and Cord Antibody Functions From SARS-CoV-2 Infection and Vaccination in Pregnancy

enthalten in: The Journal of infectious diseases | 2024

von Adhikari, E. | Lu, P. | Kang, Y. | +7

UpdateOf: bioRxiv. 2023 May 02;:. - PMID 37205338

2

An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants

enthalten in: JCI insight | 2023

von Bates, T. | Leier, H. | McBride, S. | +6

UpdateOf: medRxiv. 2023 Jan 04;:. - PMID 36656773

3

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection

enthalten in: Med (New York, N.Y.) | 2022

von Curlin, M. | Bates, T. | Guzman, G. | +4

UpdateOf: medRxiv. 2022 Apr 12;:. - PMID 35441177

4

BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age

enthalten in: Cell reports | 2022

von Bates, T. | Lu, P. | Kang, Y. | +9

UpdateOf: medRxiv. 2022 Aug 16;:. - PMID 36032979

5

A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants

enthalten in: Nature communications | 2022

von Farley, S. | Kyle, J. | Leier, H. | +7

UpdateOf: bioRxiv. 2022 Feb 15;:. - PMID 35194611

6

A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals : A Longitudinal Study in Ethiopian Health Workers

enthalten in: Vaccines | 2022

von Gelanew, T. | Mulu, A. | Abebe, M. | +11

UpdateOf: Res Sq. 2022 Jan 11;:. - PMID 35043108

7

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants

enthalten in: iScience | 2022

von Weinstein, J. | Bates, T. | Leier, H. | +3

8

High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers

enthalten in: BMC infectious diseases | 2022

von Gelanew, T. | Seyoum, B. | Mulu, A. | +27

UpdateOf: Res Sq. 2021 Jul 19;:. - PMID 34312618

9

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants

enthalten in: Science immunology | 2022

von Bates, T. | McBride, S. | Leier, H. | +9

10

Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants

enthalten in: Journal of natural products | 2022

von van Breemen, R. | Muchiri, R. | Bates, T. | +4